Log In
Print
BCIQ
Print
Print this Print this
 

TGR-1202 (formerly RP5264)

  Manage Alerts
Collapse Summary General Information
Company Rhizen Pharmaceuticals S.A.
DescriptionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) delta
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Latest Stage of DevelopmentPhase I
IndicationB cell lymphoma
Partner

TG Therapeutics Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today